Related Experiment Video
Updated: Jan 22, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.5K
Microfat and Nanofat: When and Where These Treatments Work
1Facial Plastic Surgery Institute, 521 West Southlake Boulevard, Suite 175, Southlake, TX 76092, USA.
Facial Plastic Surgery Clinics of North America
|July 9, 2019
Summary
Facial fat grafting has advanced to microfat and nanofat techniques to address aging and volume loss. This review covers their principles and application methods for improved facial rejuvenation.
Area of Science:
- Plastic Surgery
- Regenerative Medicine
- Aesthetic Dermatology
Background:
- Facial aging is significantly influenced by volume loss.
- Traditional fat grafting faced limitations in efficacy and longevity.
- Advances in fat processing have led to microfat and nanofat techniques.
Purpose of the Study:
- To review the fundamental principles of microfat and nanofat grafting.
- To demonstrate a practical technique for applying these advanced fat transfer methods.
- To highlight their role in addressing facial aging and volume deficits.
Main Methods:
- Review of current literature on microfat and nanofat processing.
- Description of a standardized surgical technique for fat harvesting and injection.
- Illustrative examples of clinical application in facial rejuvenation.
Main Results:
- Microfat and nanofat techniques offer enhanced cellular viability and tissue integration.
- These methods provide more predictable and sustained volume restoration.
- The described technique allows for precise and reproducible fat placement.
Conclusions:
- Microfat and nanofat represent significant advancements in facial fat transfer.
- These techniques effectively address facial aging concerns related to volume loss.
- The demonstrated application technique facilitates successful outcomes in facial rejuvenation.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
01:22Alzheimer's Disease: Treatment
841
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
841
01:27Open Angle Glaucoma: Treatment
969
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
969
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:20Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
01:24Treatment Strategies for Psychological Disorders
743
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
743